Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

Share Price is delayed by 15 minutes
Get Live Data
164.40    0.00 (0.00%)
Bid:
162.80
Ask:
166.00
Spread: 3.20 (1.966%)
Market Cap: -
SAN Live PriceLast checked at - London Stock Exchange

Intraday Sant Uk.10te% Share Chart

Board Changes at Santander UK plc

25 Sep 2013 08:28

RNS Number : 8455O
Santander UK Plc
25 September 2013
 



Santander UK plc

Board Change

 

Santander UK plc has today announced the appointments of Alain Dromer and Scott Wheway as Non-Executive Directors of the Board with effect from 1 October 2013.

 

These appointments have been approved by the PRA and the FCA.

 

- Ends -

 

For further details, please contact:

 

Anthony Frost

(Head of UK Communications)

020 7756 6284

James S. Johnson

(Head of Investor Relations)

020 7756 5014

For more information contact:

ir@santander.co.uk

 

 

 

Notes to Editors:

 

1. Alain Dromer is an experienced financial services executive director. He has 25 years experience in asset management and capital markets in the UK and Europe, together with nearly 10 years experience with the French Treasury.

2. Alain Dromer was previously CEO of Aviva Investors; Global Head of Group Investment Business of HSBC Investments; Head of Asset Management at CCF Credit Commercial de France and Head of Capital Markets of La Compagnie Financiere Edmond de Rothschild Banque. Prior to that he held various roles in the Government of France, French Treasury including Section Head, World Monetary Affairs & IMF, and Deputy Head/Office of Financial Markets. He is currently a director of certain Moody's subsidiaries in Europe, including Moody's Investors Service Limited; and a director of Majid Al Futtaim Trust LLC.

3. Scott Wheway is an experienced executive director from the retail sector. He has nearly 30 years of retail experience in the UK and internationally, together with over 5 years experience as a non-executive within Financial Services.

4. Scott Wheway was CEO of Best Buy Europe and MD of Boots the Chemist, prior to which he held various senior roles within Tesco plc, including Operations Director and CEO, Tesco Japan. He is currently a non-executive director of Aviva plc where he is chair of the Remuneration Committee and a Member of the CSR Committee.

5. Scott Wheway's full name is "Jonathan Scott Wheway", although he is known as "Scott".

 

 

 

Additional information about Santander UK and Banco Santander, S.A.

Banco Santander (SAN.MC, STD.N, BNC.LN) is a retail and commercial bank, based in Spain, with a presence in 10 main markets. Banco Santander is the largest bank in the euro zone by market capitalisation. Founded in 1857, Banco Santander had EUR 1,388 trillion in managed funds, 102 million customers, 14,392 branches - more than any other international bank - and 187,000 employees at the close of 2012. It is the largest financial group in Spain and Latin America. It also has significant positions in the United Kingdom, Portugal, Germany, Poland and the northeast United States. Santander had a pre-provision profit of EUR 23,559 billion in 2012, an increase of 2% from the previous year.

 

Santander UK is a leading financial services provider in the UK and offers a wide range of personal and commercial financial products and services. With 1,187 branches (including agencies), 36 regional Corporate Business Centres and c. 24,000 employees (on a group basis), Santander UK serves more than 15 million active customers as at 30 June 2013.

 

Banco Santander has a standard listing of its ordinary shares on the London Stock Exchange and Santander UK continues to have its preference shares listed on the London Stock Exchange. Nothing in this announcement constitutes or should be construed as constituting a profit forecast. Further information about Santander UK is available at the group's website: www.aboutsantander.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXNSAAXDEEF
Date   Source Headline
22nd Jan 20184:58 pmRNSArticle 8
22nd Jan 20183:02 pmRNS1119 ISE Delisting announcement
16th Jan 20184:45 pmRNSPublication of Final Terms
11th Jan 201812:04 pmRNSPublication of Final Terms
3rd Jan 201811:25 amRNSArticle 8
27th Dec 20172:25 pmRNSNotice of Early Redemption
21st Dec 20171:15 pmRNSDirectorate Change
14th Dec 20177:47 amRNSXS1656513832 - 1116 Delisting
12th Dec 20179:00 amRNSXS1656513832 - 1116 ISE Delisting
11th Dec 20175:34 pmRNSArticle 8
8th Dec 20178:03 amRNSArticle 8
27th Nov 20175:14 pmRNSNotice of Early Redemption
27th Nov 201711:06 amRNSDirectorate Change
17th Nov 20174:23 pmRNSPublication of Final Terms
26th Oct 20173:12 pmRNSPublication of Suppl.Prospcts
26th Oct 20173:10 pmRNSPublication of Suppl.Prospcts
26th Oct 20177:15 amRNS3rd Quarter Results
23rd Oct 201712:03 pmRNSDelisting
16th Oct 20175:51 pmRNSNotice of Substitution of Issuer
16th Oct 20175:47 pmRNSNotice of Substitution of Issuer
16th Oct 20175:46 pmRNSNotice of Substitution of Issuer
16th Oct 20171:09 pmRNSRing-Fencing Update
13th Oct 20173:46 pmRNSPublication of Final Terms
27th Sep 20171:07 pmRNSPublication of Final Terms
20th Sep 201712:51 pmRNSPublication of Final Terms
19th Sep 20174:25 pmRNSPurchase & Cancellation of Notes
14th Sep 20176:32 pmRNSPublication of Suppl.Prospcts
14th Sep 20176:28 pmRNSPublication of Suppl.Prospcts
14th Sep 20177:15 amRNSHalf-year Report
14th Sep 20177:15 amRNSHalf-year Report
12th Sep 201711:53 amRNSNotice of Delisting XS1606968771
1st Sep 20173:10 pmRNSPublication of Final Terms
31st Aug 20177:00 amRNSPublication of a Prospectus
31st Aug 20177:00 amRNSPublication of a Prospectus
28th Jul 20174:52 pmRNSGlobal Covered Bond Programme Supplement
28th Jul 20174:50 pmRNSMedium Term Note Programme Supplement
28th Jul 20177:15 amRNSQMS for 6 months ending 30 June 2017
14th Jul 20172:05 pmRNSNotice of Delisting
2nd Jun 20175:47 pmRNSPublication of a Prospectus
22nd May 201710:52 amRNSDirectorate Change
19th May 20172:12 pmRNSNotice of Delisting XS1561800175
18th May 201711:02 amRNSPublication of Final Terms
4th May 20174:17 pmRNSPublication of Final Terms
26th Apr 20176:27 pmRNSPublication of Suppl.Prospcts
26th Apr 20175:58 pmRNSPublication of Suppl.Prospcts
26th Apr 20177:30 amRNS1st Quarter Results
6th Apr 20176:30 pmRNSPublication of a Prospectus
31st Mar 20172:45 pmRNSResult of AGM
10th Mar 201711:56 amRNSPublication of Final Terms
23rd Feb 20175:40 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.